High Potency API Manufacturing: Containment Equipment and Scale-Up Guide

High potency API manufacturing is rarely about buying one special machine. It is a sequence of small engineering decisions: how a drum is charged, how a wet mass is transferred, how a filter is changed, how a bin is washed. Each of those decisions either reduces or multiplies the risk of operator exposure. After more than a decade building powder handling and oral solid dosage equipment for pharmaceutical, biopharmaceutical, biotechnology, nutraceutical and veterinary customers, we see the same pattern every time: containment designed into the process flow from the first layout sketch holds up, while containment added after the first industrial hygiene survey does not.

What Counts as a Highly Potent API

Highly potent active pharmaceutical ingredients do not share a single global definition. Classification systems differ between regions and even between companies, which is one of the practical difficulties of the field. In day-to-day engineering use, a compound is treated as highly potent when one or more of the following applies:

• Biological activity at a therapeutic daily dose of roughly 10 mg or less, equivalent to about 150 micrograms per kilogram of body weight
• An occupational exposure limit (OEL) at or below 10 micrograms per cubic meter of air as an eight-hour time-weighted average
• Sex hormones and certain other steroids
• Unusually high receptor selectivity, where very small quantities produce a pharmacological effect

For equipment selection, the exact label matters less than the number behind it. An OEL of 10 micrograms per cubic meter and an OEL of 0.1 micrograms per cubic meter lead to very different enclosure, transfer and cleaning solutions, and sometimes to different buildings.

Why Containment Is an Equipment Problem, Not Only a Procedure

Administrative controls and personal protective equipment have their place, but in a potent facility they are the last line of defence rather than the first. Potent actives are usually fine, free-flowing and highly dispersible, so every open transfer, manual charge, filter change or discharge releases airborne particles that are hard to remove once they are in the room.

Three product characteristics shape equipment design more than anything else:

• Small batch sizes. Because the dose is measured in micrograms, volumes are small, and equipment that cannot mix or dry efficiently at low fill levels becomes a liability.
• Frequent changeover. Short, high-value campaigns mean more cleaning cycles per kilogram of product, which pushes validation effort and cost upward.
• Limited standardization. Containment expectations vary by client and region, so equipment is often engineered around a specific OEL band instead of being chosen from a catalogue.

Mapping the Oral Solid Route for Potent Compounds

Most highly potent APIs that reach the market as tablets, granules or capsules pass through the same family of unit operations. The table below shows where containment risk concentrates in a typical solid dosage line.

The pattern is consistent: risk clusters at interfaces, meaning the points where powder enters or leaves a closed system, and around any operation that creates turbulence or requires operator access.

Containment Strategies That Hold Up in Production

Containment is a layered concept, and four layers do most of the work in a potent solid dosage facility.

Closed material transfer

Wherever the process allows, powder should travel inside a sealed pathway: vacuum conveying lines, sealed bins, docking stations and split butterfly valves. Removing two or three open transfers usually does more for an exposure assessment than upgrading the room classification.

Enclosure at the point of generation

Downflow booths, glove boxes, isolators and local exhaust ventilation capture dust at the source. The enclosure should follow the OEL band and the size of the equipment, not the other way around.

Filtration of process air

Fluid bed dryers, coaters and pneumatic conveying systems move large volumes of air. Safe-change HEPA filters, bag-in and bag-out housings, and documented filter integrity testing are baseline expectations rather than options.

Cleaning and decontamination

Residue left inside a system is a future exposure event. Equipment that can be cleaned in place, washed automatically or dismantled with minimal operator contact reduces both exposure risk and validation workload.

Coating and Drying: Where Potency Meets Process Air

Fluid bed processing is often the most demanding part of a potent solid dosage line. Drying, granulation and coating all depend on high airflow through a bed of fine particles, and the exhaust stream carries both solvent vapour and active material. Design details that matter include:

• Fully welded, crevice-free product contact surfaces with a documented surface finish
• Safe-change inlet and exhaust filtration, with sampling ports positioned for realistic access
• Solvent-compatible construction, grounding and explosion relief where organic solvents are used
• Contained discharge into bins or hoppers through a docking interface rather than an open valve

For the highest potency bands, a dedicated high containment coating machine keeps the product fully enclosed from charging through spraying to discharge, protecting the operator and the product at the same time.

BGB HR&D High-Containment, High-Efficiency Coating MachineThe BGB HR D High-Containment Coating Machine is engineered for applying coatings to highly potent tablets in the pharmaceutical industry. It is suitable for products ...View Product →

Cleaning Validation: The Quiet Deciding Factor

Cleaning validation is where many potent projects lose time. Acceptance limits come from a maximum allowable carryover calculation that starts with the smallest therapeutic dose and the largest shared surface area, and potencies in the microgram range drive those limits down sharply. A practical response usually includes:

• Equipment designed for in-place cleaning, with spray coverage that can be verified
• Separately validated bin washing for containers used in blending and transfer
• Materials and surface finishes chosen so residue is removable, not merely dissolvable
• Access points positioned so swab sampling reaches worst-case locations, not just convenient ones

A mobile cleaning station that is brought to the equipment, instead of forcing equipment to be dismantled and moved to a washroom, shortens changeover and reduces operator contact with contaminated surfaces.

QWQY Mobile CIP Cleaning StationThe QWQY Mobile CIP Cleaning Station is used in solid dosage manufacturing processes within the pharmaceutical industry. It is designed to work in conjunction with equ...View Product →

Scaling from Lab to Production Without Breaking Containment

Scale-up for potent products is not only about geometric similarity. When batches are small and containment systems are complex, the laboratory and the production suite should share the same unit operation sequence, the same transfer logic and ideally the same equipment family, so that parameters measured at five litres still mean something at two hundred. The variables that transfer least reliably are:

• Impeller tip speed and shear history during mixing and granulation
• Spray rate, droplet size and airflow during fluid bed and coating operations
• Number of closed transfers, since each interface is a potential loss and exposure point
• Fill level effects, which are more pronounced in small, potent batches

Running development work on laboratory equipment that mirrors production geometry turns the eventual technical transfer into a documentation exercise rather than a second development project. If you want to go deeper on the engineering side, we have published a detailed guide to HPAPI containment and scale-up that walks through the same decisions in more depth.

GFH R&D High-Containment Solid Dosage Production LineThe GFH R D High-Containment Solid Dosage Production Line is designed for the safe production of highly potent or hazardous solid dosage forms, such as tablets, capsul...View Product →

A Practical Checklist for HPAPI Equipment Projects

• Define the OEL band of the most potent compound the line will ever handle, and design to that band
• Count every open transfer in the process flow and remove as many as the chemistry allows
• Specify dust-free charging and contained discharge for each unit operation
• Confirm filter access and safe-change provisions before the layout is frozen
• Decide the cleaning route early: in place, automated or dismantled, and how residue will be verified
• Keep laboratory and production equipment on the same process sequence to simplify scale-up
• Document materials, surface finishes and seals for the containment dossier
• Bring industrial hygiene and validation teams in at concept stage rather than at commissioning

Working With a Process-Driven Equipment Partner

Our approach to potent products starts from the process rather than the catalogue. We begin with material characteristics, the target OEL band, batch size and the constraints of the room, then configure mixing, granulation, drying, coating, transfer and cleaning equipment as one connected line instead of a list of machines. That covers single units for laboratory and pilot work, modular systems and complete production lines, using the same process logic across every scale.

If you are planning a potent solid dosage project and want to review where the containment interfaces will fall, our engineering team is glad to look at the process flow with you. You can see how we work as a process-driven equipment partner and what the equipment range looks like in practice.